Invention Application
- Patent Title: QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
-
Application No.: US16179111Application Date: 2018-11-02
-
Publication No.: US20190071421A1Publication Date: 2019-03-07
- Inventor: Stephanos Ioannidis , Adam Charles Talbot , Bruce Follows , Alexandre Joseph Buckmelter , Minghua Wang , Ann-Marie Campbell , David R. Lancia, JR.
- Applicant: FORMA Therapeutics, Inc.
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D487/04 ; C07D471/04 ; C07D239/88
Abstract:
The present disclosure relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where R1, R2, R3, R4, R4′, X1, Y1, Y2, Y3, Y4, n, and m are described herein.
Public/Granted literature
- US10519128B2 Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Public/Granted day:2019-12-31
Information query
